BioCentury
ARTICLE | Clinical News

CPC-211small molecule inhibitor of lactate accumulation: Began ascending dose, Phase II trial in 20 patients. Brain imaging will be carried out pre- and post-dr

July 31, 1995 7:00 AM UTC

Cypros Pharmaceutical Corp. (CYPR), Carlsbad, Calif. Product: CPC-211small molecule inhibitor of lactate accumulation Indication: Stroke Status: Began ascending dose, Phase II trial in 20 patients. Br...